Results 101 to 110 of about 17,920 (197)

Localized bullous pemphigoid in the setting of chronic lymphedema. [PDF]

JAAD Case Rep
O'Connor MB, Allison SG, Trupiano N, Srikantha RP.   +3 more
europepmc   +1 more source

The morbidity of systemic steroids: analyzing its use in bullous pemphigoid. [PDF]

An Bras Dermatol
Nieto-Benito LM, Suárez-Fernández R.
europepmc   +1 more source

Complement System in Dermatological Diseases – Fire Under the Skin [PDF]

, 2015
Janna Palianus, Seppo Meri
core   +1 more source

Anti-PD-1-induced bullous pemphigoid in a renal transplant recipient. [PDF]

SAGE Open Med Case Rep
Barnawi G, Kpata AJ, Aldibane R, Kashkari S, Lazarowitz R, Khanna M.   +5 more
europepmc   +1 more source

Bullous Pemphigoid Develops Independently of DAP12. [PDF]

Biomolecules
Pigors M, Patzelt S, Brudey M, Emtenani S, Khil'chenko S, Kamaguchi M, Reichhelm N, Parker M, Bieber K, Ludwig RJ, Schmidt E.   +10 more
europepmc   +1 more source

Localized Bullous Pemphigoid Triggered by Surgical Trauma: A Case Highlighting the Koebner Phenomenon. [PDF]

Cureus
Faik Ouahab M, Chiheb S, Kelati A.
europepmc   +1 more source

Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. [PDF]

, 2006
Coelho, S, Figueiredo, A, Mariano, A, Reis, JP, Tellechea, O   +4 more
core   +1 more source

Vedolizumab-induced Bullous Pemphigoid: A Case Report with Serological Evidence and Mechanistic Insights. [PDF]

Acta Derm Venereol
Feng X, Li J, Li X, Zhang Y, Li W.
europepmc   +1 more source

The treatment of bullous pemphigoid with topical roflumilast 0.3% cream case study. [PDF]

JAAD Case Rep
Domingues E.
europepmc   +1 more source

The Role of Accessible Hematological Markers in Bullous Pemphigoid: A Systematic Review. [PDF]

Int J Mol Sci
Małolepsza A, Juczyńska K, Woźniacka A, Brzeszczyńska J, Żebrowska A.   +4 more
europepmc   +1 more source